4-155355736-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001039580.2(MAP9):c.1270A>T(p.Ile424Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000739 in 1,610,212 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001039580.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MAP9 | NM_001039580.2 | c.1270A>T | p.Ile424Leu | missense_variant | 9/14 | ENST00000311277.9 | |
MAP9-AS1 | NR_125937.1 | n.159-1353T>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MAP9 | ENST00000311277.9 | c.1270A>T | p.Ile424Leu | missense_variant | 9/14 | 1 | NM_001039580.2 | P1 | |
MAP9-AS1 | ENST00000630664.2 | n.374-1353T>A | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes ? AF: 0.000407 AC: 62AN: 152222Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000122 AC: 30AN: 246650Hom.: 0 AF XY: 0.0000899 AC XY: 12AN XY: 133446
GnomAD4 exome AF: 0.0000391 AC: 57AN: 1457872Hom.: 0 Cov.: 31 AF XY: 0.0000303 AC XY: 22AN XY: 725318
GnomAD4 genome ? AF: 0.000407 AC: 62AN: 152340Hom.: 0 Cov.: 32 AF XY: 0.000282 AC XY: 21AN XY: 74492
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2021 | The c.1270A>T (p.I424L) alteration is located in exon 9 (coding exon 8) of the MAP9 gene. This alteration results from a A to T substitution at nucleotide position 1270, causing the isoleucine (I) at amino acid position 424 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at